Psychiatry Grand Rounds-16797-------11/8/2013, Votaw Auditorium
'Medical Conditions in the Psychiatric Patient: Selected Co-Morbidities, Psychotrophic Side-Effects, and Management', David N. Burrow, M.D.
Dr. Burrow reports there is NOT any relevant financial interest/arrangement of affiliation with one or more organizations which could be perceived as a real or apparent
COI in the context of this presentation. This Continuing Medical Education activity has not received support from any commercial source.
How well did this activity meet the stated learning objectives?ExcellentAbove AverageAverageBelow AveragePoor
Identify some medical conditions to be aware of when prescribing psychotrophic medications          
Understand various management options pertinent to the conditions and psychotropic prescription          
Understand screening recommendations when they exist          
Please rate this presentation:ExcellentAbove AverageAverageBelow AveragePoor
Balanced, Objective, and Evidence Based          
Appropriate for intended audience          
Rate your level of knowledge BEFORE this educational activity          
Rate your level of knowledge AFTER this educational activity          
How well did this activity address a need you have in your practice          
Free of commercial bias    
Based on what you heard today:
Which physician attributes (core competencies) did the speaker incorporate into their presentation? Please choose all which apply:
Patient Care
Practice-Based Learning & Improvement
Medical Knowledge
System-Based Practice
Interpersonal & Communication Skills
You are seeing an 80y/o male in clinic. He has been taking Citalopram 10mg daily for depression for the last 8wks with some improvement in symptoms, & ask if a higher dose of this
medication might help him with lingering feelings of hopelessness & helplessness, poor sleep, poor concentration, & decreased energy. If the patient has no cardiac history, and EKG
showing a QTc of 448ms & is on no other medications except for a daily multivitamin, what is the maximum FDA-recommended dose of citalopram?
A). 10mg daily-- B). 20mg daily-- C). 30mg daily-- D). 40mg daily-- E). Citalopram is contraindicated in patients >= 60 years of age
Correct answer is: B          
What new information/strategy do you plan to implement into your clinical practice?
What challenges or barriers might prevent you from implementing this new information/strategy?
What topics do you feel need to be addressed in future CME activities?
If you have questions, concerns, or comments about this activity, please contact: Barbara Sucher, M.B.A., Associate Dean for CME or 423.439.8081. Form Revised 4-2013